Pfizer, Inc. (PFE): Price and Financial Metrics

Pfizer, Inc. (PFE)

Today's Latest Price: $33.75 USD

0.28 (-0.82%)

Updated Jul 8 6:40pm

Add PFE to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 213 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

PFE Stock Summary

  • Pfizer Inc's market capitalization of $187,475,639,198 is ahead of 99.33% of US-listed equities.
  • PFE's went public 34.54 years ago, making it older than 92.88% of listed US stocks we're tracking.
  • The volatility of Pfizer Inc's share price is greater than that of merely 2.49% US stocks with at least 200 days of trading history.
  • If you're looking for stocks that are quantitatively similar to Pfizer Inc, a group of peers worth examining would be NVS, MRK, CSCO, SAP, and XOM.
  • Visit PFE's SEC page to see the company's official filings. To visit the company's web site, go to
PFE Daily Price Range
PFE 52-Week Price Range

PFE Stock Price Chart Technical Analysis Charts

PFE Price/Volume Stats

Current price $33.75 52-week high $44.10
Prev. close $34.03 52-week low $27.88
Day low $33.57 Volume 23,013,801
Day high $34.37 Avg. volume 30,310,986
50-day MA $35.79 Dividend yield 4.5%
200-day MA $36.36 Market Cap 187.48B

Pfizer, Inc. (PFE) Company Bio

Pfizer discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. Its products include Lyrica, the Prevnar family of products, Enbrel, Celebrex, Lipitor, Viagra, Zyvox, Sutent, EpiPen, Toviaz, Tygacil, Rapamune, Xalkori, Inlyta, Norvasc, BeneFIX, Genotropin, ReFacto, Xyntha and Enbrel, among others. The company was founded in 1849 and is based in New York, New York.

PFE Latest News Stream

Event/TimeNews Detail
Loading, please wait...

PFE Latest Social Stream

Loading social stream, please wait...

View Full PFE Social Stream

Latest PFE News From Around the Web

Below are the latest news stories about Pfizer Inc that investors may wish to consider to help them evaluate PFE as an investment opportunity.

Morgan Stanley shared a precise timeline for the top coronavirus vaccine efforts and says we'll know if a shot works by November

Results from the first large coronavirus vaccine trials should be available by November, Morgan Stanley biotech analysts predicted Wednesday. The top vaccine programs led by Moderna, Pfizer, and AstraZeneca all have "a reasonable probability of success" in late-stage clinical trials, the analysts said in a research note to investors. These studies, called phase 3 trials, will enroll tens of thousands of volunteers and are designed to see if the shots can prevent infection or disease. Moderna and Pfizer are aiming to start phase 3 trials in July. Vaccines typically require several years, often a decade, of lab research and clinical testing to be proven safe and effective. Under the urgency of the pandemic, the leading vaccine programs are advancing with unprecedented speed. For more stor...

Business Insider | July 8, 2020

Covid-19 Research Update: The Stars and the Question Marks

While giants like Gilead Sciences and Pfizer are progressing well, many small players have witnessed setbacks in their Covid-19 research Continue reading...

Yahoo | July 8, 2020

Here's Why Pfizer Fell 14% in June

The pharma giant missed an opportunity for growth as breast cancer treatment Ibrance failed a key clinical trial.

Yahoo | July 8, 2020

Where COVID-19 vaccine trials stand

Dr. Fauci says he expects phase 3 vaccine trials to begin at the end of July. Yahoo Finance's Anjalee Khemlani joins the On the Move panel to discuss where vaccine trials stand.

Yahoo | July 8, 2020

Immunomedics: A Solid Cancer Research Play

The company has a strong pipeline of antibody-drug conjugates Continue reading...

Yahoo | July 8, 2020

Read More 'PFE' Stories Here

PFE Price Returns

1-mo -6.79%
3-mo N/A
6-mo -12.80%
1-year -20.35%
3-year 12.82%
5-year 17.97%
YTD -12.11%
2019 -6.91%
2018 24.82%
2017 15.90%
2016 4.42%
2015 7.09%

PFE Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full PFE Dividend History

Continue Researching PFE

Want to see what other sources are saying about Pfizer Inc's financials and stock price? Try the links below:

Pfizer Inc (PFE) Stock Price | Nasdaq
Pfizer Inc (PFE) Stock Quote, History and News - Yahoo Finance
Pfizer Inc (PFE) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.8866 seconds.